Fujifilm Corporation

Tokyo Medical and Dental University

Tgk Co., Inc.

Japan Breast Cancer Research Group

Hitoshi Tsuda

Johji Inazawa

Issei Imoto

Seigo Nakamura

Masakazu Toi

Takashi Sannomiya

Ken-ichi Kozaki

Futoshi Akiyama

Yasuaki Kaneko

Masafumi Kurosumi

Shuhei Komatsu

Erina Nakamura

Hiroji Iwata

Nobuaki Sato

Takaya Ishihara

Katsumasa Kuroi

Shinji Ohno

Norikazu Masuda

Kenjiro Aogi

A motor actuator includes a rotation sensor and a circuit board both of which are contained in a housing. The rotation sensor includes a rotation detection pattern for generating a detection signal indicating a rotational position of an output shaft, and an output terminal capable of outputting the detection signal from the rotation detection pattern. A terminal connection part to which the output terminal is connected is provided in the circuit board, and electronic components including a communication control unit for controlling the communications with an external control apparatus are mounted on the circuit board.

Motor actuator

It is an object of the present invention to identify a gene that exhibits behavior which is characteristic of carcinomas such as thyroid carcinoma, so as to provide a method for detecting carcinoma and a cell growth suppressing agent. The present invention provides a method for detecting carcinoma, which comprises detecting malignant transformation by detecting at least one alteration of gene existing in chromosomal regions 1q41, 3q28, 7q31.2, 8p12, 8q22.2, 8q24.21, 11q4.1, 17q12, 20q11, 9p21.3, 16q13.2, and 16q23.1 in a specimen.

Method for detecting thyroid carcinoma

An object of the present invention is to provide a method for detecting cancer and an agent for suppressing cell growth by identification of genes showing behaviors characteristic in cancer such as esophageal carcinoma. The present invention provides a method for detecting cancer, which comprises detecting canceration through detection of amplification of at least one gene existing in an 1q32-1q41 chromosomal region in a specimen.

Method for detecting esophageal carcinoma and agent for suppressing esophageal carcinoma

An administration method comprising: determining a cancer type through (i) first data indicating that an Estrogen Receptor (ER) is negative and a Human Epidermal growth factor Receptor-2 (Her2) is negative, or (ii) second data indicating that at least one of the ER and the Her2 is positive; and when the cancer type is determined through (i) the first data indicating that the ER is negative and the Her2 is negative: first performing a docetaxel administration cycle comprising administrating docetaxel to a patient multiple times at certain intervals; and then performing a 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) administration cycle comprising administrating 5-fluorouracil, epirubicin, and cyclophosphamide to the patient multiple times at certain intervals, and when the cancer type is determined through (ii) the second data indicating that at least one of the ER and Her2 is positive: first performing the FEC administration cycle; and then performing the docetaxel administration cycle.

Method for the administration of anti-cancer drugs

It is an object to be achieved by the present invention to provide a method for detecting cancer and a cell growth inhibiting agent by the identification of genes exhibiting characteristic behavior in cancers such as oral squamous-cell carcinoma. The present invention provides a method for detecting cancer, which comprises detecting at least one gene alteration existing in chromosomal region 4q35 in a specimen.

Method for detecting oral squamous-cell carcinoma

Growing community of inventors

Tokyo, Japan

Hitoshi Tsuda